Clinical Trial Update: Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is evaluating the use of primaquine for Plasmodium vivax malaria in individuals with intermediate or deficient G6PD activity. Recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose-6-phosphate Dehydrogenase Deficiency
• Plasmodium Vivax Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Vivax Malaria, G6PD Deficiency | Phase 4 | Status: RECRUITING